Brendan O'Donovan, DO
Interventional Pain Medicine · Somerset, NJNPI 1215424429
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,157 of the $3,972 with a category attached, or 79.5%. 12 manufacturers reported payments, led by Boston Scientific at 36.4% of the total. That places this record below the midpoint for interventional pain medicine clinicians in NJ, where the typical reported total is $3,760.
Across 68 payments — averaging $58.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Medtronic$1K
- Saluda Medical Americas, Inc.$503
- Biotronik NRO, Inc.$301
- ETS Wound Care LLC$135
- Vertos Medical, Inc.$76
- plus $133 from 6 others
What the payments were for
- Travel & lodging$80120%
- Food & beverage$3,15779%
- Entertainment$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 28 | $1,447 |
| Medtronic | 10 | $1,377 |
| Saluda Medical Americas, Inc. | 6 | $503 |
| Biotronik NRO, Inc. | 10 | $301 |
| ETS Wound Care LLC | 1 | $135 |
| Vertos Medical, Inc. | 6 | $76 |
| Si-bone, Inc. | 1 | $30 |
| Foundation Fusion Solutions, LLC | 2 | $27 |
| Globus Medical | 1 | $24 |
| International Rehabilitative Sciences, Inc | 1 | $21 |
| SPR Therapeutics, Inc | 1 | $16 |
| Nevro Corp. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,972 in reported general payments places this provider in the 50th percentile of 82 interventional pain medicine providers in New Jersey.
See all interventional pain medicine providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 32 | $2,028 |
| Gabapentin | 49 | $325 |
| Cyclobenzaprine Hcl | 17 | $103 |
| Oxycodone Hcl | 33 | $98 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Somerset
- Didier DemesminSomerset$33K
- Sachin ShahSomerset$4K
- Catvan leSomerset$3K
- Youssef JosephsonWest Deptford$496K
- Ali ValimahomedHolmdel$415K
- Saurabh DangEdgewater$157K
- Gabriele JasperBrick$114K
- Matthew LippChatham$67K
- Steve AydinFranklin Lakes$22K
- Kieran SlevinHainesport$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.